PKD1 and polycystic kidney disease: Evaluation of the hypothesis can begin by learning whether pregnenolone sulfate increases cytoplasmic Ca2+ in cells lacking PC1 or fibrocystin/polyductin, and whether it can reduce formation of cysts in animal models of polycystic kidney disease that lack mutations in TRPP2.